ArticlePDF Available

Characterization of bacteriocin ABC transporter ATP-binding protein produced by a newly isolated Enterococcus casseliflavus MI001 strain

Authors:
  • Vignan's Foundation for Science Technology and Research (Deemed to be University)
  • Vignans foundation for science technology and research

Abstract and Figures

Background ATP-binding cassette (ABC) transporters constitute one of the largest transporter protein families and play a role in diverse biological processes. Results In the present study, bacteriocin isolated from the Enterococcus casseliflavus MI001 strain was identified as an ABC transporter ATP-binding protein. The optimal conditions for the production of bacteriocin were found to be at 35 °C, a pH 5.5, and an incubation time of 24 h. Purification was performed using ammonium sulphate precipitation, gel filtration, and DEAE ion exchange chromatography. The bacteriocin was purified with an eightfold purification scheme resulting with a specific activity of 15,000 AU/mg. The NMR spectrum of purified bacteriocin revealed the presence of amino acids, namely lysine, methionine, cysteine, proline, threonine, tryptophan, and histidine. Further, the bacteriocin ABC transporter showed antimicrobial activity against food spoilage microorganisms. Conclusions The ABC transporter ATP-binding protein could be used as a potential alternative for food preservation, and it may be considered as a bio-preservative agent in food processing industries.
Content may be subject to copyright.
R E S E A R C H Open Access
Characterization of bacteriocin ABC
transporter ATP-binding protein produced
by a newly isolated Enterococcus
casseliflavus MI001 strain
Indira Mikkili
1
, Venkateswarulu TC
1*
, Abraham Peele Karlapudi
1
, Vidya Prabhakar Kodali
2
and Krupanidhi Srirama
1*
Abstract
Background: ATP-binding cassette (ABC) transporters constitute one of the largest transporter protein families and
play a role in diverse biological processes.
Results: In the present study, bacteriocin isolated from the Enterococcus casseliflavus MI001 strain was identified as
an ABC transporter ATP-binding protein. The optimal conditions for the production of bacteriocin were found to be
at 35 °C, a pH 5.5, and an incubation time of 24 h. Purification was performed using ammonium sulphate
precipitation, gel filtration, and DEAE ion exchange chromatography. The bacteriocin was purified with an
eightfold purification scheme resulting with a specific activity of 15,000 AU/mg. The NMR spectrum of purified
bacteriocin revealed the presence of amino acids, namely lysine, methionine, cysteine, proline, threonine,
tryptophan, and histidine. Further, the bacteriocin ABC transporter showed antimicrobial activity against food
spoilage microorganisms.
Conclusions: The ABC transporter ATP-binding protein could be used as a potential alternative for food
preservation, and it may be considered as a bio-preservative agent in food processing industries.
Keywords: Bacteriocin, Enterococcus casseliflavus MI001 strain, ABC transporter, Three-step purification, NMR
spectrum
1 Introduction
Living organisms depend on various means of trans-
port for the uptake of external nutrients and seques-
tration of waste products into the surrounding
environment [3]. ATP-binding cassette (ABC) trans-
porters are one of the largest super families of trans-
port proteins present in all forms of life. They play
diverse roles in both prokaryotes and eukaryotes.
These transporters are the primary transporters func-
tioning as both importers and exporters. Importers
mediate the uptake of essential nutrients, vitamins,
and trace metals from the surrounding environment,
whereas exporters export substrates to the surround-
ing environment. Based on the type of substrate
exported, they are categorized into various types. One
such substrate is bacteriocin, and the transporter pro-
teins exporting bacteriocin are called bacteriocin ABC
transporters. They export bacteriocin across the cell
membrane via a proteolytic function. The proteolytic
domain resides in the N-terminal region, the ABC
transporter domain is in the C-terminal and central
multi-pass transmembrane region. Bacteriocins syn-
thesized as propeptides are processed through this
ABC transporter system and exported from cells as
mature peptides [7]. Bacteriocins are secreted by ei-
ther a double glycine leader in the N-terminal part of
the pre-bacteriocin or secreted by a sec-system [12].
Due to the presence of a glycine leader on the N-
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
* Correspondence: venki_biotech327@yahoo.com;
krupanidhijuly2012@gmail.com
1
Department of Bio-Technology, Vignans Foundation for Science,
Technology & Research, Vadlamudi, Andhra Pradesh 522213, India
Full list of author information is available at the end of the article
Beni-Suef University Journal o
f
Basic and Applied Sciences
Mikkili et al. Beni-Suef University Journal of Basic and Applied Sciences
(2019) 8:5
https://doi.org/10.1186/s43088-019-0006-z
terminal side, these transporters remove the N-ter-
minal leader peptide from its bacteriocin precursor by
cleavage at a Gly-Gly bond and transport the mature
bacteriocin across the cytoplasmic membrane. The
transporter acts as an efflux system, which helps the
secretion of bacteriocins, proteins, polysaccharides,
toxic compounds, and enzymes. The importance of
these transporters in the multiple cellular functions
and biosynthetic pathways of bacteria represents a
novel strategy for the secretion of bacterial proteins
andpointsoutpotentialdrugtargets[10]. ABC trans-
porters were found to play a key role in virulence
and also identified as suitable targets for the develop-
ment of antibacterial vaccines [1,4]. However, an im-
proved understanding of the structure, function, and
action mechanism of these transporters have enabled
us to develop new approaches for investigating lead
molecules in terms of treating various diseases caused
by problematic organisms [8]. An attempt has been
made to characterize the bacteriocin ABC transporter
ATP-binding protein from the Enterococcus casselifla-
vus MI001 strain.
2 Methods
2.1 Bacterial strains and culture medium
The indicator organisms were procured from the MTCC
at the Institute of Microbial Technology, Chandigarh.
The cultures were revived and stored in refrigerated
conditions for further work. A nutrient broth medium
(Hi-Media Chemicals, India) was used for maintenance
and growing the indicator organisms for bacteriocin ac-
tivity. The de Man, Rogosa, and Sharpe (MRS) broth
medium (Hi-Media Chemicals, India) was used for pro-
duction of the bacteriocin. Finally, the MullerHinton
agar (Hi-Media Chemicals, India) medium was used for
bacteriocin activity.
2.2 Optimization of culture conditions for bacteriocin
production
2.2.1 Effect of incubation temperature and pH on
bacteriocin production
Optimum conditions were determined by growing the
test organism at a wide range of temperatures and pH
values. The MRS broth was inoculated with E. casselifla-
vus MI001 and incubated at different temperatures
A
(a) (b) (c)
Fig. 1 AEffect of temperature on bacteriocin production after 24 h against (a) P. aeruginosa, (b) S. aureus, and (c) E.coli
A
(a) (b) (c)
Fig. 2 AEffect of pH on bacteriocin production after 24 h against (a) P. aeruginosa, (b) S. aureus, and (c) E.coli at 37 °C
Mikkili et al. Beni-Suef University Journal of Basic and Applied Sciences (2019) 8:5 Page 2 of 7
(25 °C, 30 °C, 35 °C, 40 °C, and 45 °C) and pH values ran-
ging from 5 to 9 for 48 h. The samples were centrifuged
at 10,000 rpm for 15 min. The supernatant collected was
assayed for bacteriocin activity via the agar well diffusion
method [15,16].
2.2.2 Growth curve and production of bacteriocin
For growth curve measurement and production of
bacteriocin, MRS broth (dextrose20 g, peptone10
g, beef extract8 g, yeast extract4g, dipotassium
phosphate2 g, triammonium citrate2 g, sodium
acetate5 g, magnesium sulphate0.2 g, manganese
sulphate0.05 g, Tween 801 g, distilled water1000
ml) with a pH of 6.57.0 was inoculated with 1% v/v
of overnight-grown E. casseliflavus MI001, then incu-
bated at 35 °C for 36 h. For every 3-h time interval,
the optical density at 600 nm and pH were deter-
mined. Bacteriocin activity was determined every 3 h
by agar well diffusion assay. Bacteriocin activity was
measured using the formula AU/mL = 1000/V×D
(where AU stands for arbitrary unit, Vis the volume
of the cell-free supernatant, and Dis the dilution fac-
tor). Specific activity was measured as bacteriocin ac-
tivity (AU)/total protein (mg) [17].
2.2.3 Purification of bacteriocin
Cell-free supernatant was saturated using 70% ammo-
nium sulphate at ice-cold conditions (4 °C) with con-
tinuous stirring (300 rpm) and incubated overnight to
precipitate the proteins. The precipitate was centri-
fuged at 6000 rpm for 10 min and dialyzed overnight
at 4 °C using a 5 mM Tris buffer (pH 7.0). The dialy-
sis sample was subjected to gel filtration chromatog-
raphy using Sephadex G25 (13 mm radius × 150 mm
length) pre-equilibrated with 100 mM phosphate buf-
fer (pH 7.0), and the flow rate was set to 1 ml/5 min
using the same buffer. The active fractions collected
from the gel filtration chromatography were subjected
Fig. 3 Growth curve and bacteriocin production by Enterococcus casseliflavus MI001 strain
Table 1 Summary of purification profile of bacteriocin ABC transporter ATP-binding protein produced by Enterococcus casseliflavus
MI001 strain
Type of sample Volume collected (ml) Total protein (mg) Total activity (AU) Specific activity (AU/mg) Fold purification
Crude 150 129 240,000 1860 1
Ammonium sulphate precipitation
and dialysis
10 3.6 18,000 5000 2.688
Gel filtration chromatography
(SephadexG-75)
5 1.2 11,000 9166 4.927
Ion exchange chromatography
(DEAE cellulose)
2 0.32 4800 15,000 8.064
Mikkili et al. Beni-Suef University Journal of Basic and Applied Sciences (2019) 8:5 Page 3 of 7
toionexchangechromatographyusingaDEAEcellu-
lose column (13 mm radius × 150 mm length) equili-
brated with 25 mM Tris-HCl and 25150 mM NaCl
buffers (pH 7.0) [16]. The protein concentration was
determined for all fractions, and an antimicrobial
assay was performed against Staphylococcus aureus.
2.2.4 FTIR spectroscopy and NMR analysis
The purified fraction collected was subjected to FTIR ana-
lysis, and the spectrum was recorded in the frequency
range of 4000 to 400 cm
1
using Agilent Technologies.
The NMR spectrum was recorded for a purified sample
using a Bruker 400-MHz spectrophotometer at 295 K.
The purified bacteriocin sample was dissolved in methanol
and analysed for
1
Hand
13
C NMR spectra. The chemical
shifts were recorded using tetramethylsilane (TMS) as an
internal reference [9].
3 Results and discussion
3.1 Optimization of culture conditions for bacteriocin
activity
3.1.1 Effect of temperature
Temperature influences the growth and production of
bacteriocin, and it is one of the physical factors that
play an important role in the metabolic activities of
bacteria. From Fig. 1A (a, b, c), it was found that the
Fig. 4 Purification of bacteriocin by gel filtration chromatography. The blue line shows the protein content in terms of absorbance values at
280 nm, and the brown line shows the peak pertaining to bacteriocin activity
Fig. 5 FT-IR spectral analysis of purified bacteriocin from Enterococcus casseliflavus MI001 strain
Mikkili et al. Beni-Suef University Journal of Basic and Applied Sciences (2019) 8:5 Page 4 of 7
E. casseliflavus MI001 grown in MRS broth at 35 °C
showed high antimicrobial activity against the indicator
organisms Pseudomonas aeruginosa,S. aureus,and
Escherichia coli after 24 h of incubation, which disap-
peared after 48 h of incubation. After an increase in
temperature up to 40 °C for 24 h of incubation, bacteri-
ocin production was at a minimum, as it showed a re-
duction in antimicrobial activity. Bacteriocin activity
was not observed at temperatures of 25 °C, 30 °C, and
45 °C when incubated for 24 and 48 h. Zotta et al. [18]
also reported that the cultivation of Lactobacillus plan-
tarum at 25 °C reduced the growth compared to the op-
timal temperature of 35 °C. Our results suggest that the
bacterium is surviving in human body conditions; this
feature helps in that this organism could be used as a
probiotic. In consonance, a recent study by Phumisanti-
phong et al. [13] reported that the bacteriocin produc-
tion from Enterococcus faecalis 478 was found to be
high at 37 °C.
3.2 Effect of pH
The synthesis of metabolites and metabolic activities
of bacteria are usually affected by varying the pH. It
was found that E. casseliflavus MI001 incubated for
24 h at pH 5.08.0 supported the growth and produc-
tion of bacteriocin with good antimicrobial activity, as
represented in Fig. 2A (a, b, c). The bacteriocin activ-
ity was not observed at acidic pH values and above a
pH of 9.0. This result suggests that the bacteriocin
activity is not due to organic acid production by
bacteria. Iyapparaj et al. [6]reportedthathighbac-
teriocin production was recorded above a pH of 5.0,
and reduced activity was observed at a pH of 9.0.
3.3 Growth curve and production of bacteriocin
Growth of the bacterium under various physical con-
ditions, along with medium components, is import-
ant for the production of bacteriocin. MRS is a
complex synthetic medium which supports bacteri-
ocin production. Higher bacteriocin production was
observed at a temperature of 35 °C, a pH of 5.5, and
27 h of incubation time, as represented in Fig. 3.
Bacteriocin production was high during the exponen-
tial phase and was found to be 1500 AU/ml. A re-
duction in bacteriocin production was observed at
temperatures above 35 °C, pH values below 4.5, and
incubation times in excess of 30 h. In a previous re-
port by Todorov et al. [17], it was found that the
production of bacteriocin was high at 37 °C and pH
5.5. According to Fabricio et al. [2], bacteriocin pro-
duction was high at 37 °C, pH 5.0, and an incubation
time of 8 h during the exponential growth phase.
3.4 Purification of bacteriocin
The crude extract produced by Enterococcus casseliflavus
MI001 was purified by a three-step procedure, as repre-
sented in Table 1. The crude extract precipitated with
70% ammonium sulphate increased the specific activity
about 2.6-fold. The active sample purified by gel filtra-
tion chromatography showed two peaks, the specific ac-
tivity increased about 4.9-fold, and the fractions from 24
to 28 showed high antimicrobial activity against the S.
aureus (15 mm) (Fig. 4). In anion exchange chromatog-
raphy, an 8.0-fold increase in specific activity at 15,000
AU/mg was observed. During each purification step, a
considerable loss in protein concentration and a marked
increase in the specific activity of the bacteriocin were
observed. The purified fraction containing bacteriocin
revealed the molecular weight of a 22-kDa protein via
Table 2 Wave number represents the presence of bonds
Wave number cm
1
Possible bonds Intensity
3367.186 Amine stretch (NH) Medium
1635.441 Alkene (C=C) Variable
1096.238 CN Medium, weak
Table 3
13
C NMR spectral data. Various groups of carbon being detected in purified bacteriocin ABC transporter isolated from E.
casseliflavus MI001 strain
13
C NMR spectra standard values Purified bacteriocin sample NMR spectra (predicted values)
Carbon environment Chemical shift (ppm) Chemical shift (ppm)
C=O (in ketones) 205220 217.51, 207.26
C in aromatic rings 125150 146.65
C=C (in alkenes) 115140 115.46, 114.12, 112.90
C=C (in alkynes) 90100 96.57
RCH
2
O5090 80.02, 61.16, 58.24
RCH
2
Cl 3060 49.86, 49.64, 49.43, 49.21, 49.01, 48.79, 48.57
RCH
2
NH
2
3065
Mikkili et al. Beni-Suef University Journal of Basic and Applied Sciences (2019) 8:5 Page 5 of 7
SDS-PAGE [5]. In a recent study reported by Qianwen
et al. [14], it was found that the bacteriocin produced by
Enterococcus faecalis TG2 has a molecular weight of
6.33 kDa protein using a three-step purification
procedure.
3.5 FTIR spectrum and NMR spectral analysis
The FTIR spectral analysis showed the presence of a
C=C stretch and amine group coupled with a CN
group (Fig. 5). The correlation of various peaks is
represented in Table 2. A previous study by Kadir-
velu et al. [9] reported the presence of an amide and
hydroxyl group coupled with CH. Further,
13
C
NMR and
1
H NMR analyses were carried out to dis-
cover the different amino acids and carbon com-
pounds forming the molecular structure of the
bacteriocin of Enterococcus casseliflavus MI001. The
NMR spectra obtained were compared with the
standard
13
C NMR spectrum presented in Table 3.
From Fig. 6, it can be seen that the
13
CNMR
showed the presence of 17 carbons, of which 2 are
in C=O (ketones), 1 is in an aromatic ring, 3 are in
C=C (alkenes), 1 is in C=C (alkyne), 3 are in R-
CH
2
O, and 7 are in the carbon environment R-
CH
2
Cl and RCH
2
NH
2
.The
1
H NMR spectrum was
compared with the peaks of a standard spectrum of
20 amino acids. Of the 20 amino acids, seven, viz.,
lysine, methionine, cysteine, proline, threonine, tryp-
tophan, and histidine, were involved in forming the
peptide structure of the bacteriocin of E. casselifla-
vus MI001, as represented in both Fig. 6b(Right)
and Table 4. In a previous study by Neha et al. [11],
it was reported that the purified bacteriocin of
Lactobacillus brevis UN examined by a
1
HNMR
spectrum exhibited the following amino acids: pro-
line, glutamic acid, arginine, leucine, isoleucine, and
serine.
4 Conclusions
In this study, the optimized conditions for the bac-
teriocin production and three-step procedure for
purification yielded a bacteriocin peptide molecule
with antimicrobial activity. The purified bacteriocin
molecular weight was found to be 22 kDa, which
matched the results from MALDI-TOF. The
13
C
NMR and
1
H NMR analyses revealed that the carbon
environment and combinations of the unique amino
acids in purified bacteriocin result in antibacterial
activity, which has been reported for the first time
through the present study. The antimicrobial activity
of this ABC transporter bacteriocin has attracted
much attention due to the antimicrobial resistance
of the bacteria, which can be used as a next-gener-
ation antimicrobial in various fields.
Fig. 6
13
C NMR spectra (Left) and
1
H spectra (Right) of purified bacteriocin isolated from E. casseliflavus MI001 strain
Table 4
1
H NMR spectral data, delta (ppm) of various amino acids detected in purified bacteriocin of E. casseliflavus MI001
Name of the amino acid Chemical shift (ppm)standard values Chemical shift (ppm)predicted values
Lysine 1.7 1.713
Methionine 2.0 2.065
Cysteine 3.2 3.270
Proline 2.13.6 3.3203.391
Threonine 45 4.866
Tryptophan 6.57.8 7.332
Histidine 6.58.5 8.433
Mikkili et al. Beni-Suef University Journal of Basic and Applied Sciences (2019) 8:5 Page 6 of 7
Abbreviations
ABC: ATP-binding cassette; MTCC: Microbial Type Culture Collection;
NMR: Nuclear magnetic resonance
Acknowledgements
The authors would like to acknowledge the facilities supported by DST-FIST
and Vignans Foundation for Science Technology and Research (Deemed to
be University), Guntur, India.
Authorscontributions
MI carried out the experimental studies and drafted the manuscript. SK and
KV participated in the design of the study. KA and TCV participated in
optimization studies. KA and TCV conceived of the study, participated in its
design and coordination, and helped to draft the manuscript. All authors
read and approved the final manuscript.
Funding
Not applicable.
Availability of data and materials
All data generated or analysed during this study are included in this
published article.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1
Department of Bio-Technology, Vignans Foundation for Science,
Technology & Research, Vadlamudi, Andhra Pradesh 522213, India.
2
Department of Bio-Technology, Vikrama Simhapuri University, Nellore,
Andhra Pradesh 524001, India.
Received: 5 July 2019 Accepted: 26 July 2019
References
1. Davidson AL, Elie D, Cedric O, Jue C (2008) Structure, function, and evolution
of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev 72:317364
2. Fabricio LT, Bruna CG, Elaine CPDM (2011) Partial purification and
characterization of a bacteriocin produced by Enterococcus faecium 130
isolated from mozzarella cheese. Ciencia e Tecnologia de Alimentos 31:
155159
3. Gizaw M, Anandakumar P (2017) A review on ATP binding cassette (ABC)
transporters. Int J Pharma Res Health Sci 5:16071615
4. Helen SG, Richard WT (2004) ATP-binding cassette transporters are targets
for the development of antibacterial vaccines and therapies. Infect Immun
72:67576763
5. Indira M, Venkateswarulu TC, Vidya Prabhakar K, Abraham Peele K,
Krupanidhi S (2018) Isolation and characterization of bacteriocin producing
Enterococcus casseliflavus and its antagonistic effect on Pseudomonas
aeruginosa. Karbala Int J Modern Sci 4:361368
6. Iyapparaj P, Thirumalai M, Ramasamy R, Santhiyagu P, Chandrasekaran K,
Grasian I, Arunachalam P (2013) Optimization of bacteriocin production by
Lactobacillus sp. MSU3IR against shrimp bacterial pathogens. Aquatic
Biosystems 9:12
7. Jan M, Gunter D, Jos V, Chuanwu X (2001) Processing and export of peptide
pheromones and bacteriocins in Gram negative bacteria. Trends Microbiol
9(4):164168
8. Joni T, Glenn ST (2010) ABC transporters in microorganisms. Expert Rev
Anti-Infect Ther 8(4):375377
9. Kadirvelu J, Venkatasubramanian V, Perumal JA, Appukuttan S,
Muthukandan U (2015) Characterization of an antibacterial compound,
2-hydroxyl indole-3-propanamide, produced by lactic acid bacteria
isolated from fermented batter. Appl Biochem Biotechnol 177:137147
10. Murphy TF, Brauer AL, Johnson AKC (2016) ATP-binding cassette (ABC)
transporters of the human respiratory tract pathogen, Moraxella catarrhalis:
role in virulence. PLoS One 11(7):e0158689
11. Neha G, Nivedita S, Ahlawat OP (2014) Purification and characterization
of bacteriocin produced by Lactobacillus brevis UN isolated from
Dhulliachar: a traditional food product of north East India. Indian J
Microbiol 54(2):185189
12. Ness IF, Dzung BD, Yasuyoshi I (2014) Enterococcal bacteriocins and
antimicrobial proteins that contribute to niche control. In: Gilmore MS,
Clewell DB, Ike Y et al (eds) Enterococci: from commensals to leading
causes of drug resistant infection. Massachusetts Eye and Ear Infirmary,
Boston
13. Phumisantiphong U, Siripanichgon K, Reamtong O, Diraphat P (2017) A
novel bacteriocin from Enterococcus faecalis 478 exhibits a potent
activity against vancomycin-resistant enterococci. PLoS One 12(10):
e0186415
14. QianwenX,JinW,RenpengD,FangkunZ,HanY,ZhijiangZ(2018)
Purification and characterization of bacteriocin produced by a strain
of Enterococcus faecalis TG2. Appl Biochem Biotechnol 184:11061119
15. Sivaramasamy E, Neelamegam A, Packiyam M, Thangavel B (2014)
Production, purification and characterization of bacteriocin from
Lactobacillus murinus AU06 and its broad antibacterial spectrum. Asian Pac J
Trop Biomed 4(11):S305S311
16. Sure KP, Kotnis PV, Bhagwat PK, Ranveer RC, Dandge PB, Sahoo AK
(2016) Production and characterization of bacteriocin produced by
Lactobacillus viridescence (NICM 2167). Braz Arch Biol Technol 59:
e16150518
17. Todorov SD, Manuela V, Bernadette DGF, Wilhelm HH (2013) Partial
characterization of bacteriocins produced by three strains of Lactobacillus
sakei, isolated from salpicao, a fermented meat product from North-West of
Portugal. Food Control 30:111121
18. Zotta T, Guidone A, Ianniello RG, Parente E, Ricciardi A (2013) Temperature
and respiration affect the growth and stress resistance of Lactobacillus
plantarum C17. J Appl Microbiol 115(3):848858
PublishersNote
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Mikkili et al. Beni-Suef University Journal of Basic and Applied Sciences (2019) 8:5 Page 7 of 7
... NMR studies were performed to examine the protein structure of purified bacteriocin according to the standard procedure [35]. After dissolving in methanol, the purified bacteriocin was analyzed for 1 H spectra using FT-NMR spectrometer. ...
... The 1 H NMR spectrum of bacteriocin of E. casseliflavus MI001 was compared with the peaks of a standard spectrum of 20 amino acids. Of the 20 amino acids, seven, viz., lysine, methionine, cysteine, proline, threonine, tryptophan, and histidine, were involved in forming the peptide structure [35]. In accordance to the earlier reports, in the present study, the 1 H NMR spectrum of bacteriocin of L. lactis strain CH 3 recorded the presence of six amino acids namely histidine, tryptophan, threonine, proline, methionine, and lysine. ...
Article
The current study aimed to screen bacteriocin producing LAB from different dairy products and evaluation of their biological properties. Initially, 12 (4-chess, 4-curd, and 4-yohurt) LAB species were isolated and only 4 isolates alone were selected based on their clear yellow halo zone around the colonies in the selective medium. The selected 4 isolates were identified based on their morphological and biochemical characteristics. Among them, the strain CH3 have showed better antimicrobial effects on selected human pathogens. The isolated strain CH3 were further identified as Lactococcus lactis strain CH3 (MZ636710) by SEM imaging and 16 s rRNA molecular sequencing. Bacteriocin was extracted from L. lactis strain CH3 and partially purified using 60 % ammonium sulphate and then completely purified by G-50 column chromatography. The purified bacteriocin showed a specific activity of 5859.37 AU/mg in 24.7 % of recovery and 10.9-fold purification. The molecular weight of bacteriocin was 3.5 kDa as observed in SDS-PAGE. The bacteriocin showed sensitivity to proteolytic enzymes and resistance to high temperature, wide range of pH, organic solvents and detergents. FT-IR spectral studies of bacteriocin detected the existence of OH/NH-stretching, CH, and COC and CO bonds. NMR spectrum showed one doublet and 4 various singlet peaks at different ppm, indicating the occurrence of six amino acids in the structure of purified bacteriocin. The purified bacteriocin have shown stronger antimicrobial and anti-biofilm activity against selected human pathogens at 100 μg/mL. SEM showed the evidence of structural deformation and loss of membrane integrity of bacterial cells treated with bacteriocin. Bacteriocin exhibited greater DPPH radical scavenging potential with an EC50 value of 12.5 μg/mL. Bacteriocin have not shown significant toxicity on normal human dermal fibroblast (NHDF) cells (83.2 % at 100 μg/ mL). Furthermore, in silico studies using molecular modeling and docking were performed to know the proteins involved in antimicrobial action. The results suggests that bacteriocin could be an alternative to combat AMR pathogens and more suitable for food and dairy industries to preserve food without contamination.
... ABC transporter ATP-binding protein YtrB (ytrB_2) was detected in strain Lev. brevis AcCh91, which are associated with bacteriocin activity [119]. The ability of Lev. ...
Article
Full-text available
Consumption of naturally fermented milk (NFM) products is the dietary culture in India. The mountainous people of Arunachal Pradesh in India prepare the assorted artisanal home-made NFM products from cow and yak milk. Previously, we isolated and identified 76 strains of lactic acid bacteria (LAB) from NFM products of Arunachal Pradesh, viz. mar, chhurpi and churkam. We hypothesized that some of these LAB strains may possess probiotic potentials; hence, we investigated the probiotic potentials of these strains. On the basis of in vitro and genetic screening for probiotic attributes including haemolytic ability, 20 LAB strains were selected out of 76 strains, for further analysis. Using in silico analysis, viz. multivariate heatmap and PCA (principal component analysis) biplot, Levilactobacillus brevis AcCh91 was selected as the most promising probiotic strain, which was further characterized by the whole-genome analysis. Lev. brevis AcCh91 showed the highest survival rate of 93.38% in low pH and 86.68 ± 2.69% in low bile and the highest hydrophobicity average of 86.34 ± 5.53%. This strain also showed auto-aggregation and co-aggregation with antimicrobial properties against the pathogens, showed ability to produce beta-galactosidase and cholesterol reduction property and, most importantly, produced GABA, an important psychobiotic element. Genomic analysis of Lev. brevis AcCh91 showed the presence of genes corresponding to GABA, vitamins, amino acids, cholesterol reduction, immunomodulation, bioactive peptides and antioxidant activity. The absence of antimicrobial-resistant genes and virulence factors was observed. Hence, genome analysis supports the probiotic potentials of Lev. brevis AcCh91, which may be further investigated to understand its health-promoting properties.
Chapter
Full-text available
Bioprospecting of natural molecules for the development of medicines, nutraceuticals, and bioactive leads has gained attention in the industrial market. The bioactive compounds from microorganisms have huge commercial demand in various industries. The immense biodiversity of microorganisms has remained unexplored from extreme environments, which is a valuable resource for bioprospecting. Understanding the interaction of biological molecules in the living systems and communications with the surrounding environment are vital steps for exploring novel bioactive compounds from nature. The identification and screening of bioactive compounds from microbial origin have significant potential in the biotechnological field. The biological compounds from microbes act as potential molecules for the development of products and various formulations on the industrial scale. The understanding of the potential bioactive compounds from microbes using metagenomics approach will contribute to bioactive leads in medicine, clinical, agriculture, and pharmaceutical fields. This chapter discusses the exploration of bioprospecting resources, methods used for prospecting of biomolecules from microbes such as culturable, nonculturable, and in silico bioprospecting. This chapter also discusses bioinformatics tools that help in finding novel genes, enzymes, and metabolites for expansion in various industries and making of profit derived from biological means. Further, it emphasized on different bioactive compounds from microorganisms as potential lead molecules in various industries.
Article
Full-text available
Microbial oil is one of alternative sources for biofuel and value-added chemical production in biorefining process of lignocellulosic biomass. The bottleneck of this process is the low conversion rate of lignocellulose biomass to the target product. This research aims to optimize microbial oil production as raw material for biorefining process from agricultural waste by using Plackett–Burman (PB) design and Response Surface Methodology (RSM). Acid-hydrolysates of cassava pulp and sugarcane bagasse were converted to bio-oil by fermentation activities of two oleaginous yeasts, designated as MSU2 and Ka28. The fermentation parameters were screened by PB design to identify their impacts on oil yield, and the condition of each parameter was optimized by RSM to maximized oil yield. The predicted optimal condition obtained from RSM provided the highest lipid yield at 34.56 and 21.85% from hydrolysates of cassava pulp and sugarcane bagasse, respectively. Then, fatty acid compositions in oil were analyzed by GCMS, and our results demonstrated that palmitic acid and oleic acid were the major constituents at 72.95 and 195.01 mg/g-crude lipid, respectively. These fatty acid distribution profiles were suitable for application in biodiesel production and suggested the utilization of agricultural waste in biorefining process.
Article
Full-text available
The discovery of antimicrobial bacteriocin molecules with broad-spectrum activity against bacterial infections caused by spoilage microorganisms is vital for food safety. In this study, a potential bacteriocin-producing bacterium was isolated, screened and confirmed as Enterococcus casseliflavus MI001 by 16s rDNA sequencing. The bacteriocin peptide was purified and analysed by MALDI-TOF, which revealed the presence of a bacteriocin ABC transporter protein with a molecular mass of 22.53 kDa. The purified bacteriocin gave a final yield of 2.0%, with a specific activity of 15,000 AU/mg. The bacteriocin showed antagonistic activity against Pseudomonas aeruginosa and has potential as an antioxidant.
Article
Full-text available
The emergence of multidrug-resistant enterococci (MDRE) and particularly vancomycin-resistant enterococci (VRE) is considered a serious health problem worldwide, causing the need for new antimicrobials. The aim of this study was to discover and characterize bacteriocin against clinical isolates of MDRE and VRE. Over 10,000 bacterial isolates from water, environment and clinical samples were screened. E. faecalis strain 478 isolated from human feces produced the highest antibacterial activity against several MDRE and VRE strains. The optimum condition for bacteriocin production was cultivation in MRS broth at 37°C, pH 5–6 for 16 hours. The bacteriocin-like substance produced from E. faecalis strain EF478 was stable at 60°C for at least 1 hour and retained its antimicrobial activity after storage at -20°C for 1 year, at 4°C for 6 months, and at 25°C for 2 months. A nano-HPLC electrospray ionization multi-stage tandem mass spectrometry (nLC-ESI-MS/MS) analysis showed that the amino acid sequences of the bacteriocin-like substance was similar to serine protease of E. faecalis, gi|488296663 (NCBI database), which has never been reported as a bacteriocin. This study reported a novel bacteriocin with high antibacterial activity against VRE and MDRE.
Article
Full-text available
The aims of this study were to purify and characterize a bacteriocin produced by a strain of Enterococcus faecalis TG2 and to test the safety of the strain. In this work, the active peptide was purified through precipitation with 70% saturated ammonium sulfate, cation-exchange chromatography, and gel filtration. The specific activity of purified bacteriocin was 30,073.42 AU/mg of protein, which corresponded to a 33.34-fold increase. The molecular mass of the purified bacteriocin was 6.3362 kDa determined by LC-MS/MS. The ten amino acid of N-terminal was MTRSKKLNLR and the ten amino acid of C-terminal was ATGGAAGWKS. The activity of the bacteriocin was unaffected by pH 2–10 and thermostable but was sensitive to proteolytic enzymes. The antimicrobial activity of the bacteriocin was not affected by metal ions. Tween-20, Tween-80, Triton X-100, and EDTA did not affect the bacteriocin activity and SDS was able to increase the activity of bacteriocin. Bacteriocin activity was not lost after treatment by < 8% NaCl. Inhibitory spectrum of the bacteriocin showed a wide range of activities against other lactic acid bacteria, food-spoilage, and food-borne pathogens. Ent. faecalis TG2 was sensitive to tetracycline and erythromycin but resistant to ampicillin, gentamicin, kanamycin, and chloramphenicol. Results from PCR indicated that Ent. faecalis TG2 did not harbor any virulence genes. The study suggests that Ent. faecalis TG2 and its bacteriocin might be used as bio-preservatives in food products.
Article
Full-text available
Moraxella catarrhalis is a human respiratory tract pathogen that causes otitis media (middle ear infections) in children and respiratory tract infections in adults with chronic obstructive pulmonary disease. In view of the huge global burden of disease caused by M. catarrhalis, the development of vaccines to prevent these infections and better approaches to treatment have become priorities. In previous work, we used a genome mining approach that identified three substrate binding proteins (SBPs) of ATP-binding cassette (ABC) transporters as promising candidate vaccine antigens. In the present study, we performed a comprehensive assessment of 19 SBPs of 15 ABC transporter systems in the M. catarrhalis genome by engineering knockout mutants and studying their role in assays that assess mechanisms of infection. The capacity of M. catarrhalis to survive and grow in the nutrient-limited and hostile environment of the human respiratory tract, including intracellular growth, account in part for its virulence. The results show that ABC transporters that mediate uptake of peptides, amino acids, cations and anions play important roles in pathogenesis by enabling M. catarrhalis to 1) grow in nutrient-limited conditions, 2) invade and survive in human respiratory epithelial cells and 3) persist in the lungs in a murine pulmonary clearance model. The knockout mutants of SBPs and ABC transporters showed different patterns of activity in the assay systems, supporting the conclusion that different SBPs and ABC transporters function at different stages in the pathogenesis of infection. These results indicate that ABC transporters are nutritional virulence factors, functioning to enable the survival of M catarrhalis in the diverse microenvironments of the respiratory tract. Based on the role of ABC transporters as virulence factors of M. catarrhalis, these molecules represent potential drug targets to eradicate the organism from the human respiratory tract.
Article
Full-text available
The present study focused on the production optimization of bacteriocin by Lactobacillus viridescence NICM 2167 followed by its purification and characterization. The bacteriocins are antimicrobial peptides produced by many Gram positive and Gram negative bacteria.The bacteriocin produced by LAB (lactic acid bacteria) received attention in recent years due to their potential application as natural preservatives in food. Bacteriocinproduced by Lactobacillus viridescence showed broad range of antimicrobial activity against food borne pathogens. Production parameters were optimized showing highest production of bacteriocinin MRS broth with pH= 7.0 incubated at 37°C for 48 h. Bacteriocin was purified in two steps involving ammonium sulphate precipitation followed by gel filtration using Sephadex G-100. Purified bacteriocin with single band on SDS-PAGE showed molecular weight of 8.3 kDa. This purified bacteriocin was stable over wide range of pH (4-10) as well as temperatures (4°C-121°C) suggesting it as a potent candidate for preservation of various foods.
Article
Full-text available
Lactic acid bacteria are known to produce numerous antimicrobial compounds that are active against various pathogens. Here, we have purified and characterized a novel low-molecular-weight (LMW) antimicrobial compound produced by Lactobacillus and Pediococcus isolated from fermented idly and uttapam batter. The LMW compound was extracted from cell-free supernatant using ice-cold acetone, purified by gel permeation and hydrophobic interaction chromatography. It exhibited antimicrobial activity against Gram-positive and Gram-negative pathogenic bacteria sparing the probiotic strains like Lactobacillus rhamnosus. The molecular weight of the LMW compound was identified as 204 Da using LC-MS-ESI. In addition, the structure of the compound was predicted using spectroscopic methods like FTIR and NMR and identified as 2-hydroxyl indole-3-propanamide. The LMW compound was differentiated from its related compound, tryptophan, by Salkowski reaction and thin-layer chromatography. This novel LMW compound, 2-hydroxyl indole-3-propanamide, may have an effective application as an antibiotic which can spare prevailing probiotic organisms but target only the pathogenic strains.
Article
Full-text available
Objective: To study the production, purification and characterization of bacteriocin from Lactobacillus murinus AU06 isolated from marine sediments and its broad spectrum of inhibition against fish pathogens. Methods: The selected strain was used in production, purification and characterized of bacteriocin. In addition, purified bacteriocin was tested for its antimicrobial activity against fish pathogens. Results: In the present study, the bacteriocin production was found to be higher at 35 °C, pH 6.0 and was purified to 4.74 fold with 55. 38 U/mg of specific activity with the yield of 28.92%. The molecular weight of the purified bacteriocin was estimated as 21 kDa. The purified bacteriocin exhibited complete inactivation of antimicrobial activity when treated with proteinase K, pronase, chymotrypsin, trypsin, pepsin and papain. The purified bacteriocin exhibited broad inhibitory spectrum against both Gram positive and negative bacteria. Conclusions: It is concluded that the ability of bacteriocin in inhibiting a wide-range of pathogenic bacteria is of potential interest for food safety and may have future applications in food preservative.
Article
Full-text available
Lactic acid bacteria are important in foods as potential probiotics and also due to the ability to produce antimicrobial compounds that can contribute for biopreservation. In this work, the bacteriocin produced by the food isolate Enterococcus faecium 130 was partially purified and characterized. The compound was active against Gram-positive bacteria, including Listeria monocytogenes. It was produced after 4 days of storage at a broad temperature range (4 to 37 °C); it was stable at pH ranging from 2 to 10 with no loss of activity after heating at 100°C for 15 minutes. Bacteriocin was partially purified by the adsorption-desorption technique, and the analysis by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) showed a molecular mass of 3.5 to 6.5 kDa. These data encourage studies on application of this bacteriocin in food systems as an additional hurdle to microbial growth.
Article
Full-text available
A bacteriocin producing strain Lactobacillus brevis UN isolated from Dulliachar—a salted pickle and identified by biochemical and molecular methods. L. brevis UN was found to produce bacteriocin with broad spectrum activity against spoilage causing/food borne pathogens viz. L. monocytogenes, C. perfringens, S. aureus, L. mesenteroides, L. plantarum and B. cereus. Bacteriocin production was optimized through classical one variable at a time method. The isolate showed maximum bacteriocin production at early stationary phase, pH 4.0, temperature 35 °C and with an inoculum size of 1.5 OD @ 10 %. Bacteriocin produced by L. brevis UN was purified to homogeneity by single step gel exclusion chromatography and was most active at pH 6.0 and 7.0, stable up to 100 °C and was proteinaceous in nature. The results of NMR revealed the presence of proline, glutamic acid, aspartic acid, leucine, isoleucine and serine in its peptide structure. PCR amplification analysis determined that bacteriocin encoded gene in L. brevis UN was plasmid bound.
Chapter
Enterococci, which belong to the group of lactic acid bacteria (LAB), have received increased attention in recent years for various reasons (Fisher & Phillips, 2009; Franz, Huch, Abriouel, Holzapfel, & Gálvez, 2011; Leavis, Bonten, & Willems, 2006). While lactobacilli, another group of LAB, have been shown to confer numerous benefits and are often regarded as health-bringing organisms, enterococci have become more recognized as emerging human pathogens despite the fact that they are as numerous as the lactobacilli in our gastrointestinal tractgastrointestinal tract. Enterococcus faecalis is the dominant Enterocuccus in the gastrointestinal tract, followed by E. faecium; however, E. avium and E. hirae, as well as other enterococcal species, are frequently found in human stool samples. The commensal/probiotic role of enterococci in humans and animals has evolved through thousands of years in mutual coexistence—but the ability of the enterococci to behave in a way that causes problems to human health is only beginning to be understood. Virulence, which may evolved as an adaptation to the “modern lifestyle,” including the profligate use of antibiotics in medical practice and animal husbandry, needs to be understood and limited where possible. On the other side, enterococci have many positive traits that have been appreciated in food fermentation and preservation, and may also serve as probiotics to promote health. Bacteriocin-producing bacteria are found in all environments. In many LAB isolates, bacteriocin production has been examined by biochemical and genetic studies, and the bacteriocins produced by enterococci are often similar to those produced by other lactic acid bacteria. A classification scheme has been developed for bacteriocins produced by Gram-positive bacteria, and most of this information is based on findings from LAB. Although classification is still a disputed issue, two major classes of heat-stable, ribosomally synthesized antimicrobial peptides are well defined. Class I constitutes the lantibiotics, while Class II constitutes the unmodified non-lantibiotics. Bacteriocins within different classes and subclasses also have been isolated and characterized in enterococci (Cotter, Hill, & Ross, 2005; Nes, Diep, Håvarstein, Brurberg, Eijsink, & Holo, 1996; Nes, Yoon, & Diep, 2007). One of the most striking findings so far is the almost complete absence of lantibiotics among enteroccci, with the only exceptions being cytolysin and enterocin W (Coburn & Gilmore, 2003; Cox, Coburn, & Gilmore, 2005; Sawa, et al., 2012). Most of the characterized enterocins belong to the Class II bacteriocins and a few are heat-labile lytic enzymes. The latter were previously classified as bacteriocins, but are now included in a distinct class of antimicrobials (Cotter, Hill, & Ross, 2005). The hemolytic bacteriocin (cytolysin), the circular AS-48, and bacteriocin 21 have been known as E. faecalis bacteriocins for a long time, and they have been genetically and biochemically well characterized (Clewell D. B., 1981; Gilmore, 1991; Gilmore, Coburn, Nallapareddy, & Murray, 2002; Gilmore, Segarra, Booth, Bogie, Hall, & Clewell, 1994; Haas, Shepard, & Gilmore, 2002; Ike, Clewell, Segarra, & Gilmore, 1990). Many bacteriocin producers have been identified and investigated from infection-derived E. faecalis or E. faecium isolates. From E. faecalis isolates, for example, bacteriocin 31 (Tomita, Fujimoto, Tanimoto, & Ike, 1996) and bacteriocin 41 (Tomita, Kamei, & Ike, 2008) have been studied; and from E. faecium, there are bacteriocin 43 (Todokoro, Tomita, Inoue, & Ike, 2006), bacteriocin 32 (Nes, Diep, Håvarstein, Brurberg, Eijsink, & Holo, 1996), and bacteriocin 51 (Yamashita, Tomita, Inoue, & Ike, 2011). Besides enterococcal bacteriocins of clinical origin, bacteriocins from enterococci of food origins have been studied, and several bacteriocins from E.faecium isolates have been identified and characterized. These include enterocin L50A/L50B (Cintas L. M., Casaus, Holo, Hernandez, Nes, & Håvarstein, 1998), enterocin Q (Cintas L. M., et al., 2000; Criado, et al., 2006), enterocin A (Aymerich, Holo, Håvarstein, Hugas, Garriga, & Nes, 1996; Nilsen, Nes, & Holo, 1998), enterocin P (Cintas L. M., Casaus, Håvarstein, Hernández, & Nes, 1997; Kang & Lee, 2005), enterocin B (Casaus, Nilsen, Cintas, Nes, Hernández, & Holo, 1997) and others. Many enterocins have also been characterized from various enterococcal species and from many environments, and the most thoroughly characterized enterocins are summarized in Table 1. Most of the characterized enterocins are from E. faecium and E. faecalis, but enterocins have also been isolated from E. muntii, E. avium, E. hirae, and E. durans (see Table 1). The bacteriocin-producing enterococci are by and large isolated from food, waste, and the feces and gastrointestinal tract of humans and animals, but may also be isolated from other sources. Fermented food, specimens from human infections, and feces from healthy babies seem to be particularly good niches for isolating bacteriocin-producing enterococci (see Figure 1). It seems likely that most enterococci originate from the digestive tract of humans and animals, a notion which is in line with the finding that the same bacteriocins are identified in enterococci isolated from many environments, which most often include those of human origin.